Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MolMed SPA

Latest From MolMed SPA

MolMed Pulls Zalmoxis Cell Therapy In EU

The Italian biotech will redirect investment, initially reserved for Zalmoxis, to other activities that would better meet its business objectives.

Europe Clinical Trials

Fresh Or Frozen? Orchard Aims For Cryopreserved Gene Therapy Approvals Using Pivotal Trials With Fresh Cell Formulations

Orchard aims to submit three ex vivo autologous gene therapies for approval by the end of 2021, helped by a new regenerative medicine advanced therapy designation (for a rare primary immunodeficiency syndrome) and a breakthrough therapy designation (for another rare primary immunodeficiency).

Drug Approval Standards Gene Therapy

Kiadis Raises €28m As Cell Therapy Nears Commercialization

The funding comes as the Dutch biotech closes in on a potential conditional approval and closure of its acquisition of CytoSen.

Financing ImmunoOncology

EMA Discusses Pivotal Role Of RWE For Six Drugs

The European Medicines Agency explains how it used real-word evidence during recent deliberations for six products. 
Europe Drug Approval Standards
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Parent & Subsidiaries
  • MolMed SPA
  • Senior Management
  • Claudio Bordignon, MD, Pres. & CEO
    Enrico Cappelli, CFO
    Gian Paolo, MD, Dir., Research
    Holger Neecke, PhD, Mgr., Bus. Dev.
  • Contact Info
  • MolMed SPA
    Phone: (39) 2 21277 1
    Via Olgettina 58
    Milan, 20132